Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients.
作者信息
Tau Noam, Yahav Dafna, Schneider Shira, Rozen-Zvi Benaya, Abu Sneineh Marwan, Rahamimov Ruth
机构信息
Department of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
Am J Transplant. 2021 Aug;21(8):2910-2912. doi: 10.1111/ajt.16700. Epub 2021 Jun 14.
Abstract
摘要
相似文献
1
Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients.接种疫苗的肾移植受者感染新冠病毒的严重后果。
Am J Transplant. 2021 Aug;21(8):2910-2912. doi: 10.1111/ajt.16700. Epub 2021 Jun 14.
2
Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2.肾移植受者对新型冠状病毒mRNA疫苗BNT162b2的血清学反应取决于既往对新型冠状病毒的接触情况。
Am J Transplant. 2021 Nov;21(11):3806-3807. doi: 10.1111/ajt.16726. Epub 2021 Jul 10.
3
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.血清学反应和抗 SARS-CoV-2 疫苗接种的临床保护作用，以及免疫抑制药物在一组肾移植患者中的作用。
Viruses. 2022 Sep 2;14(9):1951. doi: 10.3390/v14091951.
4
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体在肾移植受者中的持续存在情况。
Am J Transplant. 2021 Jun;21(6):2307-2310. doi: 10.1111/ajt.16469. Epub 2021 Jan 17.
5
Management of COVID-19 in Liver Transplant Recipients With Immunosuppressant Therapy: Experiences of an Iranian Transplant Registry.COVID-19 管理在接受免疫抑制剂治疗的肝移植受者中的应用：伊朗移植登记处的经验。
Exp Clin Transplant. 2022 Mar;20(3):285-292. doi: 10.6002/ect.2020.0526. Epub 2021 Jun 3.
6
Clinical outcomes of SARS-CoV-2 infection in kidney transplant recipients on belatacept: a single-center experience.接受贝拉西普治疗的肾移植受者感染新型冠状病毒2的临床结果：单中心经验
Transpl Infect Dis. 2024 Apr;26(2):e14253. doi: 10.1111/tid.14253. Epub 2024 Feb 13.
7
Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients.免疫抑制对两名肾移植受者抗 SARS-CoV-2 血清转化的影响。
Transpl Infect Dis. 2021 Feb;23(1):e13423. doi: 10.1111/tid.13423. Epub 2020 Aug 8.
8
COVID-19 infection in kidney transplant recipients: endocrine and metabolic issues.肾移植受者的新型冠状病毒肺炎感染：内分泌和代谢问题
Minerva Endocrinol (Torino). 2021 Sep;46(3):293-295. doi: 10.23736/S2724-6507.20.03209-5. Epub 2020 May 15.
9
Immunosuppressant Management in Renal Transplant Patients with COVID-19.COVID-19 肾移植患者的免疫抑制剂管理。
Biomed Res Int. 2021 Oct 14;2021:9318725. doi: 10.1155/2021/9318725. eCollection 2021.
10
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.移植前接种疫苗的肾移植受者对 SARS-CoV-2 疫苗保持优越的体液反应。
Clin Transplant. 2021 Dec;35(12):e14478. doi: 10.1111/ctr.14478. Epub 2021 Sep 29.
引用本文的文献
1
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.AZD7442与SARS-CoV-2疫苗在极易感染SARS-CoV-2病毒的免疫抑制患者中的适应性临床试验（快速保护）：一项多中心、介入性开放标签、随机对照试验方案
BMJ Open. 2025 Jan 20;15(1):e084345. doi: 10.1136/bmjopen-2024-084345.
2
Vaccination for solid organ transplanted patients: Recommendations, efficacy, and safety.实体器官移植患者的疫苗接种：建议、疗效与安全性
World J Transplant. 2024 Dec 18;14(4):92172. doi: 10.5500/wjt.v14.i4.92172.
3
Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis.接受肾脏替代治疗患者的三剂新冠疫苗接种方案的免疫原性和安全性：一项系统评价和荟萃分析
Kidney Dis (Basel). 2024 Jan 19;10(2):107-117. doi: 10.1159/000536308. eCollection 2024 Apr.
4
Understanding Concerns about COVID-19 and Vaccination: Perspectives from Kidney Transplant Recipients.了解肾移植受者对新冠病毒病及疫苗接种的担忧：观点剖析
Vaccines (Basel). 2023 Jun 22;11(7):1134. doi: 10.3390/vaccines11071134.
5
Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.肾移植受者接种第三剂 mRNA 疫苗后持续存在的 SARS-CoV-2 特异性免疫缺陷。
Am J Transplant. 2023 Jun;23(6):744-758. doi: 10.1016/j.ajt.2023.03.014. Epub 2023 Mar 24.
6
COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients.接种疫苗的肾移植受者中的新冠病毒突破性感染
Vaccines (Basel). 2022 Nov 11;10(11):1911. doi: 10.3390/vaccines10111911.
7
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients.实体器官移植受者中的新型冠状病毒 2 型疫苗接种
Vaccines (Basel). 2022 Aug 30;10(9):1430. doi: 10.3390/vaccines10091430.
8
Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot Study.肾移植受者在接种疫苗前后2周停用霉酚酸不会增加对SARS-CoV-2疫苗的反应——一项非随机对照试验研究
Front Med (Lausanne). 2022 Jun 10;9:914424. doi: 10.3389/fmed.2022.914424. eCollection 2022.
9
Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.印度一家三级医疗中心对感染和未感染新冠病毒的肾移植受者接种疫苗后抗刺突抗体反应的分析。
Clin Kidney J. 2022 Mar 3;15(7):1312-1321. doi: 10.1093/ckj/sfac057. eCollection 2022 Jul.
10
A Comprehensive Comparison of Clinical Presentation and Outcomes of Kidney Transplant Recipients with COVID-19 during Wave 1 versus Wave 2 at a Tertiary Care Center, India.印度一家三级医疗中心中，新冠疫情第一波与第二波期间肾移植受者的临床表现及预后综合比较
Int J Nephrol. 2022 Jun 2;2022:9088393. doi: 10.1155/2022/9088393. eCollection 2022.
本文引用的文献
1
Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine.接种BNT162b2疫苗的肺移植受者的早期体液反应。
Lancet Respir Med. 2021 Jun;9(6):e52-e53. doi: 10.1016/S2213-2600(21)00184-3. Epub 2021 May 5.
2
Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients - a prospective cohort study.BNT162b2 mRNA疫苗在心脏移植受者中的免疫原性——一项前瞻性队列研究。
Eur J Heart Fail. 2021 Sep;23(9):1555-1559. doi: 10.1002/ejhf.2199. Epub 2021 May 14.
3
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.肾移植受者对 SARS-CoV-2 mRNA 疫苗的抗体反应：一项前瞻性队列研究。
Clin Microbiol Infect. 2021 Aug;27(8):1173.e1-1173.e4. doi: 10.1016/j.cmi.2021.04.028. Epub 2021 May 3.
4
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.肝移植受者对 SARS-CoV-2 疫苗的免疫原性较低。
J Hepatol. 2021 Aug;75(2):435-438. doi: 10.1016/j.jhep.2021.04.020. Epub 2021 Apr 21.
5
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.COVID-19 于实体器官移植受者：来自美国震中地区的初步报告。
Am J Transplant. 2020 Jul;20(7):1800-1808. doi: 10.1111/ajt.15941. Epub 2020 May 10.
Zotero 插件